Mechanism-based inhibition of HsaD: A C-C bond hydrolase essential for survival of Mycobacterium tuberculosis in macrophage

10Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Mycobacterium tuberculosis remains the leading cause of death by a bacterial pathogen worldwide. Increasing prevalence of multidrug-resistant organisms means prioritizing identification of targets for antituberculars. 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (HsaD), part of the cholesterol metabolism operon, is vital for survival within macrophage. The C-C bond hydrolase, HsaD, has a serine protease-like catalytic triad. We tested a range of serine protease and esterase inhibitors for their effects on HsaD activity. As well as providing a potential starting point for drug development, the data provides evidence for the mechanism of C-C bond hydrolysis. This screen also provides a route to initiate development of fragment-based inhibitors. Inhibitors of HsaD, a novel target for the treatment of tuberculosis, are identified in Mycobacterium tuberculosis. © 2013 Federation of European Microbiological Societies.

Cite

CITATION STYLE

APA

Ryan, A., Keany, S., Eleftheriadou, O., Ballet, R., Cheng, H. Y., & Sim, E. (2014, January). Mechanism-based inhibition of HsaD: A C-C bond hydrolase essential for survival of Mycobacterium tuberculosis in macrophage. FEMS Microbiology Letters. https://doi.org/10.1111/1574-6968.12302

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free